Human-Led Content Creation Services for Biopharma Companies
Content creation for biopharma companies includes the research, writing and editing of the pages, articles and guides a biopharma company publishes for patients, caregivers and healthcare professionals.
How does human-led content compare with AI-generated content for biopharma companies?
Human-led content is researched, written and edited by people. This is how it differs from pages generated by AI with no writer or editor involved.
| Human-led content from Emulent | AI-generated content with no editor | |
|---|---|---|
| Where the facts come from | Interviews with your team, your own records and named sources | Whatever is already published online, blended together |
| Who checks it | An editor, then someone at your biopharma company before it goes live | Often no one, so errors and made-up details can be published |
| How it reads | Like your biopharma company, with examples patients, caregivers and healthcare professionals recognize | Like every other site in the industry |
| How search engines treat it | Original detail and first-hand experience are what Google’s guidance on helpful content asks for | Google’s spam policies target pages mass-produced with little effort or originality |
Which biopharma company content problems does Emulent solve?
The content problems biopharma companies bring us most often:
What do content creation services for biopharma companies include?
Every step is done by a person, from the first interview to the final edit.
Topic research
We find the questions patients, caregivers and healthcare professionals ask, in search data and in your inbox, and pick the topics most likely to lead to trial and partnering inquiries.
Interviews with your team
A writer interviews the people who do the work. Their answers, examples and numbers are what make the content yours.
Writing
Disease education, patient and caregiver resources, pipeline pages and corporate stories, each routed through medical, legal and regulatory review. Each piece is optimized for SEO and AI search.
Editing and fact-checking
An editor reviews every piece for accuracy, clarity and tone. Facts, figures and quotes are checked against their source.
Your review and publishing
You approve each piece before it goes live. We format it, add images and publish it to your site.
Updates and reporting
Older pieces are reviewed and refreshed on a schedule, and a monthly report shows traffic and trial inquiries and partnering requests.
How does Emulent create content for biopharma companies?
Five steps, each one handled by a person.
Interview
A writer talks with your team about the work, the customers and the questions patients, caregivers and healthcare professionals ask.
Plan
You get a content calendar with topics, formats and dates. You approve it before writing starts.
Write
The writer drafts each piece from the interview, your records and checked sources, and optimizes it for SEO and AI search: clear headings, direct answers and the terms your customers search for.
Edit and approve
An editor reviews the draft, then it goes to you. Nothing is published without your approval.
Publish and measure
We publish the piece, track traffic and trial inquiries and partnering requests, and use the results to plan the next month.
What do biopharma companies ask about content creation?
Is the content written by people or by AI?
By people. A writer researches and writes every piece, and an editor signs off on it. Where we use software, it is for keyword data, interview transcripts and grammar checks.
How does content fit our review process?
We build medical, legal and regulatory review into the schedule, deliver annotated references with each draft and track every change.
What does content creation cost for biopharma companies?
Content is priced per piece or as a flat monthly plan, based on the number and length of pieces. You see the price before any work starts.
How long does one piece take?
Most pieces take two to three weeks from the interview to publishing, including your review.
Is your biopharma company’s content written by people who know the work?
Human-led content for biopharma companies starts with a conversation with the people who do the job.
Let’s Talk